Published in Arch Ophthalmol on October 01, 2002
Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension. Clin Ophthalmol (2010) 1.45
Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study. Ophthalmology (2008) 1.27
Prostamides (prostaglandin-ethanolamides) and their pharmacology. Br J Pharmacol (2007) 1.23
Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension. Br J Ophthalmol (2006) 1.18
Efficacy and tolerability of bimatoprost versus travoprost in patients previously on latanoprost: a 3-month, randomised, masked-evaluator, multicentre study. Br J Ophthalmol (2009) 1.06
Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension. BMC Ophthalmol (2007) 0.99
Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin-ethanolamides) in the feline iris. Br J Pharmacol (2006) 0.99
Ophthalmologist-patient communication, self-efficacy, and glaucoma medication adherence. Ophthalmology (2014) 0.99
Brimonidine in the treatment of glaucoma and ocular hypertension. Ther Clin Risk Manag (2006) 0.97
An observational study of bimatoprost 0.01% in treatment-naïve patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial. Clin Ophthalmol (2012) 0.96
The management of glaucoma and intraocular hypertension: current approaches and recent advances. Ther Clin Risk Manag (2006) 0.96
Long-term safety evaluation of bimatoprost ophthalmic solution 0.03%: a pooled analysis of six double-masked, randomized, active-controlled clinical trials. Clin Ophthalmol (2011) 0.93
Current primary open-angle glaucoma treatments and future directions. Clin Ophthalmol (2012) 0.93
A randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprost. Clin Ophthalmol (2010) 0.91
Studies using isolated uterine and other preparations show bimatoprost and prostanoid FP agonists have different activity profiles. Br J Pharmacol (2005) 0.91
A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients. Graefes Arch Clin Exp Ophthalmol (2004) 0.91
Enhanced eyelashes: prescription and over-the-counter options. Aesthetic Plast Surg (2010) 0.86
Bimatoprost for eyelash growth in Japanese subjects: two multicenter controlled studies. Aesthetic Plast Surg (2014) 0.86
Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials. Clin Ophthalmol (2014) 0.85
Bimatoprost 0.01% vs bimatoprost 0.03%: a 12-month prospective trial of clinical and in vivo confocal microscopy in glaucoma patients. Eye (Lond) (2014) 0.85
Management of hypotrichosis of the eyelashes: Focus on bimatoprost. Clin Cosmet Investig Dermatol (2010) 0.84
Provider Education about Glaucoma and Glaucoma Medications during Videotaped Medical Visits. J Ophthalmol (2014) 0.82
Evolving paradigms in the medical treatment of glaucoma. Int Ophthalmol (2006) 0.82
Bimatoprost 0.01% in treatment-naïve patients with open-angle glaucoma or ocular hypertension: an observational study in the Korean clinical setting. BMC Ophthalmol (2014) 0.82
Comparison between bimatoprost and latanoprost-timolol fixed combination for efficacy and safety after switching patients from latanoprost. Clin Ophthalmol (2015) 0.81
Reporting of noninferiority and equivalence randomized trials for major prostaglandins: a systematic survey of the ophthalmology literature. Trials (2008) 0.81
Bimatoprost 0.01 % for previously treated patients with open-angle glaucoma or ocular hypertension in the Korean clinical setting. Jpn J Ophthalmol (2015) 0.80
Progress toward personalized medicine for glaucoma. Expert Rev Ophthalmol (2009) 0.80
Late-day intraocular pressure-lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial. BMC Ophthalmol (2014) 0.80
Clinical options for the reduction of elevated intraocular pressure. Ophthalmol Eye Dis (2012) 0.79
Effect of Korean Red Ginseng supplementation on dry eye syndrome in glaucoma patients - A randomized, double-blind, placebo-controlled study. J Ginseng Res (2014) 0.77
Pharmacogenetics of ophthalmic topical beta-blockers. Per Med (2008) 0.77
Bimatoprost effects on aqueous humor dynamics in monkeys. J Ophthalmol (2010) 0.76
Effect of bimatoprost on ocular circulation in patients with open-angle glaucoma or ocular hypertension. Graefes Arch Clin Exp Ophthalmol (2004) 0.76
Iris heterochromia and unilateral eyelash hypertrichosis. JAMA (2015) 0.75
An evaluation of the safety and efficacy of bimatoprost for eyelash growth in pediatric subjects. Clin Ophthalmol (2016) 0.75
Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects. J Clin Aesthet Dermatol (2015) 0.75
Bimatoprost 0.03% for the Treatment of Eyelash Hypotrichosis: A Pooled Safety Analysis of Six Randomized, Double-masked Clinical Trials. J Clin Aesthet Dermatol (2015) 0.75
Exploring the influence of patient-provider communication on intraocular pressure in glaucoma patients. Patient Educ Couns (2015) 0.75
Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications. Clin Ophthalmol (2017) 0.75
Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology (2005) 7.37
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology (2010) 7.30
Macular segmentation with optical coherence tomography. Invest Ophthalmol Vis Sci (2005) 5.53
Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using StratusOCT. Invest Ophthalmol Vis Sci (2004) 4.81
Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology (2011) 4.61
A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am J Ophthalmol (2003) 4.52
Detection of macular ganglion cell loss in glaucoma by Fourier-domain optical coherence tomography. Ophthalmology (2009) 4.44
Ultrahigh speed 1050nm swept source/Fourier domain OCT retinal and anterior segment imaging at 100,000 to 400,000 axial scans per second. Opt Express (2010) 4.10
Optical coherence tomography measurement of macular and nerve fiber layer thickness in normal and glaucomatous human eyes. Ophthalmology (2003) 3.90
Optical coherence tomography longitudinal evaluation of retinal nerve fiber layer thickness in glaucoma. Arch Ophthalmol (2005) 3.75
Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol (2011) 3.63
High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology (2006) 3.51
Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography. Arch Ophthalmol (2006) 3.13
Characterization of outer retinal morphology with high-speed, ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci (2008) 3.09
Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina (2011) 3.04
Ultrahigh-speed optical coherence tomography for three-dimensional and en face imaging of the retina and optic nerve head. Invest Ophthalmol Vis Sci (2008) 3.01
A critical appraisal and comparison of the quality and recommendations of glaucoma clinical practice guidelines. Ophthalmology (2011) 2.82
Comparison of three optical coherence tomography scanning areas for detection of glaucomatous damage. Am J Ophthalmol (2005) 2.54
Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol (2007) 2.53
Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci (2011) 2.53
Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology. Ophthalmology (2005) 2.51
Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology (2012) 2.48
Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular hole pathology and repair. Ophthalmology (2004) 2.38
OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program. Headache (2011) 2.31
Optical coherence tomography (OCT) macular and peripapillary retinal nerve fiber layer measurements and automated visual fields. Am J Ophthalmol (2004) 2.25
Tracking optical coherence tomography. Opt Lett (2004) 2.21
A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum (2005) 2.20
Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye. Invest Ophthalmol Vis Sci (2002) 2.19
Analysis of macular volume in normal and glaucomatous eyes using optical coherence tomography. Am J Ophthalmol (2003) 2.16
Anaesthesia techniques for cataract surgery: a survey of delegates to the Congress of the International Council of Ophthalmology, 2002. Clin Experiment Ophthalmol (2005) 2.12
Noninvasive volumetric imaging and morphometry of the rodent retina with high-speed, ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci (2006) 2.11
Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial. Arch Ophthalmol (2006) 2.10
High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy. Arch Ophthalmol (2007) 2.09
Ultra-high resolution optical coherence tomography assessment of photoreceptors in retinitis pigmentosa and related diseases. Am J Ophthalmol (2006) 2.03
Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma. PLoS Genet (2012) 2.00
Optic nerve head and retinal nerve fiber layer analysis: a report by the American Academy of Ophthalmology. Ophthalmology (2007) 2.00
INTRAOCULAR PRESSURE IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE INTRAVITREAL IMPLANT IN THE 3-YEAR MEAD STUDY. Retina (2016) 1.92
Ultrahigh-resolution optical coherence tomography in glaucoma. Ophthalmology (2005) 1.92
Optical coherence tomography measurement of nerve fiber layer thickness and the likelihood of a visual field defect. Am J Ophthalmol (2002) 1.89
Ocular surface disease and quality of life in patients with glaucoma. Am J Ophthalmol (2011) 1.85
Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthalmic Surg Lasers Imaging (2006) 1.83
Identification and assessment of Schlemm's canal by spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci (2010) 1.83
Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol (2010) 1.82
Comparison of spectral/Fourier domain optical coherence tomography instruments for assessment of normal macular thickness. Retina (2010) 1.82
Stage 0 macular holes: observations by optical coherence tomography. Ophthalmology (2004) 1.81
Comparison of visual field defects using matrix perimetry and standard achromatic perimetry. Ophthalmology (2006) 1.77
The water drinking test. Am J Ophthalmol (2010) 1.77
Effects of age on optical coherence tomography measurements of healthy retinal nerve fiber layer, macula, and optic nerve head. Ophthalmology (2009) 1.76
Topographic differences in the age-related changes in the retinal nerve fiber layer of normal eyes measured by Stratus optical coherence tomography. J Glaucoma (2011) 1.74
Quantification of photoreceptor layer thickness in normal eyes using optical coherence tomography. Retina (2006) 1.72
Optical coherence tomography: history, current status, and laboratory work. Invest Ophthalmol Vis Sci (2011) 1.71
Ultrahigh-resolution optical coherence tomography of surgically closed macular holes. Arch Ophthalmol (2006) 1.67
Contact transscleral neodymium:yttrium-aluminum-garnet laser cyclophotocoagulation Long-term outcome. Ophthalmology (2004) 1.65
Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am J Ophthalmol (2009) 1.64
Optical coherence tomography scan circle location and mean retinal nerve fiber layer measurement variability. Invest Ophthalmol Vis Sci (2008) 1.59
Diagnostic tools for glaucoma detection and management. Surv Ophthalmol (2008) 1.58
Correlation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edema. Retina (2010) 1.56
Active retinal tracker for clinical optical coherence tomography systems. J Biomed Opt (2005) 1.54
Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema. Ophthalmology (2013) 1.52
Idiopathic juxtafoveal retinal telangiectasis: new findings by ultrahigh-resolution optical coherence tomography. Ophthalmology (2005) 1.49
A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension. Ophthalmology (2003) 1.48
An assessment of the health and economic burdens of glaucoma. Am J Ophthalmol (2011) 1.46
LAP-BAND for lower BMI: 2-year results from the multicenter pivotal study. Obesity (Silver Spring) (2013) 1.46
Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes. Invest Ophthalmol Vis Sci (2011) 1.46
Anterior segment imaging: ultrasound biomicroscopy. Ophthalmol Clin North Am (2004) 1.45
Ultrahigh-resolution optical coherence tomography in patients with decreased visual acuity after retinal detachment repair. Ophthalmology (2006) 1.44
In vivo corneal high-speed, ultra high-resolution optical coherence tomography. Arch Ophthalmol (2007) 1.43
Definition of glaucoma: clinical and experimental concepts. Clin Experiment Ophthalmol (2012) 1.43
Analysis of risk factors that may be associated with progression from ocular hypertension to primary open angle glaucoma. Clin Experiment Ophthalmol (2002) 1.42
Assessment of artifacts and reproducibility across spectral- and time-domain optical coherence tomography devices. Ophthalmology (2009) 1.42
Retinal nerve fibre layer and visual function loss in glaucoma: the tipping point. Br J Ophthalmol (2011) 1.42
Optic nerve head assessment: comparison of Cirrus optic coherence tomography and Heidelberg Retinal Tomograph 3. Clin Experiment Ophthalmol (2014) 1.41
Detection of glaucoma progression by population and individual derived variability criteria. Br J Ophthalmol (2012) 1.40
Total Human Eye Allotransplantation: Developing Surgical Protocols for Donor and Recipient Procedures. Plast Reconstr Surg (2016) 1.38
Glaucoma detection with the Heidelberg retina tomograph 3. Ophthalmology (2006) 1.38
Automated assessment of the optic nerve head on stereo disc photographs. Invest Ophthalmol Vis Sci (2008) 1.36
Peripapillary schisis in glaucoma patients with narrow angles and increased intraocular pressure. Am J Ophthalmol (2006) 1.35
Redefining lamellar holes and the vitreomacular interface: an ultrahigh-resolution optical coherence tomography study. Ophthalmology (2006) 1.35
Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant. Ophthalmology (2012) 1.32
Detection of differentially expressed glycogenes in trabecular meshwork of eyes with primary open-angle glaucoma. Invest Ophthalmol Vis Sci (2006) 1.30
Peripapillary nerve fiber layer thickness profile determined with high speed, ultrahigh resolution optical coherence tomography high-density scanning. Invest Ophthalmol Vis Sci (2007) 1.30
Retinal nerve fiber layer assessment using optical coherence tomography with active optic nerve head tracking. Invest Ophthalmol Vis Sci (2006) 1.28
Prophylaxis for second eye involvement in leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite. Am J Ophthalmol (2005) 1.27
Combining nerve fiber layer parameters to optimize glaucoma diagnosis with optical coherence tomography. Ophthalmology (2008) 1.27
Optical Coherence Tomography (OCT) in ophthalmology: introduction. Opt Express (2009) 1.26
Optical coherence tomography machine learning classifiers for glaucoma detection: a preliminary study. Invest Ophthalmol Vis Sci (2005) 1.25
Clinical application of objective perimetry using multifocal visual evoked potentials in glaucoma practice. Arch Ophthalmol (2005) 1.24
Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, assessment of function related to vision, and the Glaucoma Quality of Life-15. J Glaucoma (2008) 1.24
Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure. Surv Ophthalmol (2001) 1.24
Ultrahigh-resolution spectral domain optical coherence tomography imaging of the lamina cribrosa. Ophthalmic Surg Lasers Imaging (2008) 1.23
Spectral oximetry assessed with high-speed ultra-high-resolution optical coherence tomography. J Biomed Opt (2007) 1.22
Retinal nerve fiber layer thickness measurement comparability between time domain optical coherence tomography (OCT) and spectral domain OCT. Invest Ophthalmol Vis Sci (2009) 1.22
Reproducibility of spectral-domain optical coherence tomography total retinal thickness measurements in mice. Invest Ophthalmol Vis Sci (2010) 1.22
Retinal vessel segmentation on SLO image. Conf Proc IEEE Eng Med Biol Soc (2008) 1.21
Techniques and outcomes of minimally invasive trabecular ablation and bypass surgery. Br J Ophthalmol (2013) 1.19
3D visualization of aqueous humor outflow structures in-situ in humans. Exp Eye Res (2011) 1.18
Ultrasound activates the TM ELAM-1/IL-1/NF-kappaB response: a potential mechanism for intraocular pressure reduction after phacoemulsification. Invest Ophthalmol Vis Sci (2003) 1.17
Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. Invest Ophthalmol Vis Sci (2010) 1.17
Glaucoma discrimination of segmented cirrus spectral domain optical coherence tomography (SD-OCT) macular scans. Br J Ophthalmol (2012) 1.17
Macular assessment using optical coherence tomography for glaucoma diagnosis. Br J Ophthalmol (2012) 1.16